Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

The Alabama Senate Thursday approved a bill that would require health insurance companies to cover prostate cancer screenings ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...